PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,110,277 | -90.6% | 101,378 | -87.7% | 0.00% | -85.7% |
| Q2 2023 | $32,979,614 | +78.2% | 823,050 | +81.5% | 0.01% | +75.0% |
| Q1 2023 | $18,503,254 | +51.4% | 453,400 | +43.3% | 0.00% | +33.3% |
| Q4 2022 | $12,218,752 | +240.1% | 316,466 | +368.6% | 0.00% | – |
| Q3 2022 | $3,593,000 | +76.0% | 67,541 | +93.0% | 0.00% | – |
| Q2 2022 | $2,041,000 | -84.8% | 35,000 | -80.2% | 0.00% | -100.0% |
| Q1 2022 | $13,468,000 | +51.5% | 176,484 | +19.5% | 0.00% | +200.0% |
| Q4 2021 | $8,887,000 | +331.2% | 147,690 | +301.3% | 0.00% | – |
| Q3 2021 | $2,061,000 | -74.5% | 36,800 | -72.4% | 0.00% | -100.0% |
| Q2 2021 | $8,083,000 | +10.1% | 133,214 | +27.2% | 0.00% | 0.0% |
| Q1 2021 | $7,341,000 | -30.2% | 104,750 | -40.4% | 0.00% | -50.0% |
| Q4 2020 | $10,524,000 | +5.5% | 175,864 | +6.0% | 0.00% | +100.0% |
| Q3 2020 | $9,971,000 | -12.7% | 165,862 | -23.8% | 0.00% | -50.0% |
| Q2 2020 | $11,417,000 | +168.0% | 217,603 | +71.3% | 0.00% | +100.0% |
| Q1 2020 | $4,260,000 | -71.7% | 127,033 | -61.7% | 0.00% | -71.4% |
| Q4 2019 | $15,033,000 | +17.8% | 331,846 | -1.0% | 0.01% | +40.0% |
| Q3 2019 | $12,757,000 | -29.6% | 335,122 | -19.5% | 0.01% | -37.5% |
| Q2 2019 | $18,114,000 | +114.1% | 416,524 | +87.4% | 0.01% | +100.0% |
| Q1 2019 | $8,460,000 | -20.5% | 222,280 | -10.1% | 0.00% | -33.3% |
| Q4 2018 | $10,641,000 | -37.7% | 247,339 | -28.8% | 0.01% | -25.0% |
| Q3 2018 | $17,081,000 | +350.8% | 347,532 | +193.9% | 0.01% | +166.7% |
| Q2 2018 | $3,789,000 | +24.5% | 118,237 | +21.0% | 0.00% | +50.0% |
| Q1 2018 | $3,044,000 | -76.5% | 97,713 | -65.6% | 0.00% | -75.0% |
| Q4 2017 | $12,976,000 | +221.7% | 284,267 | +164.6% | 0.01% | +166.7% |
| Q3 2017 | $4,034,000 | -32.3% | 107,422 | -14.0% | 0.00% | -40.0% |
| Q2 2017 | $5,960,000 | -46.4% | 124,955 | -48.8% | 0.01% | -54.5% |
| Q1 2017 | $11,124,000 | +187.9% | 243,954 | +103.9% | 0.01% | +120.0% |
| Q4 2016 | $3,864,000 | -91.7% | 119,630 | -91.2% | 0.01% | -89.4% |
| Q3 2016 | $46,783,000 | +158.5% | 1,367,129 | +154.8% | 0.05% | +135.0% |
| Q2 2016 | $18,100,000 | +86.5% | 536,602 | +324.5% | 0.02% | +81.8% |
| Q4 2015 | $9,706,000 | +159.3% | 126,397 | +38.8% | 0.01% | +175.0% |
| Q3 2015 | $3,743,000 | +4303.5% | 91,071 | +7521.0% | 0.00% | – |
| Q2 2015 | $85,000 | -97.2% | 1,195 | -96.4% | 0.00% | -100.0% |
| Q1 2015 | $2,983,000 | +73.4% | 33,578 | +89.2% | 0.00% | +50.0% |
| Q3 2014 | $1,720,000 | +73.7% | 17,748 | +64.7% | 0.00% | +100.0% |
| Q2 2014 | $990,000 | +12.2% | 10,779 | -14.5% | 0.00% | 0.0% |
| Q1 2014 | $882,000 | +44000.0% | 12,601 | +44903.6% | 0.00% | – |
| Q4 2013 | $2,000 | -99.5% | 28 | -99.7% | 0.00% | -100.0% |
| Q3 2013 | $414,000 | +500.0% | 8,606 | +262.8% | 0.00% | – |
| Q2 2013 | $69,000 | – | 2,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 563,415 | $21,753,453 | 4.80% |
| Gagnon Advisors, LLC | 180,331 | $6,962,579 | 4.70% |
| Spyglass Capital Management LLC | 868,686 | $33,539,966 | 2.69% |
| Tamarack Advisers, LP | 100,000 | $3,861,000 | 1.99% |
| ARMISTICE CAPITAL, LLC | 1,892,000 | $73,050,120 | 1.27% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 276,590 | $10,679,140 | 0.99% |
| RICE HALL JAMES & ASSOCIATES, LLC | 437,285 | $16,883,574 | 0.97% |
| Rock Springs Capital Management LP | 1,032,600 | $39,868,686 | 0.96% |
| OUTFITTER FINANCIAL LLC | 25,860 | $998,455 | 0.91% |
| Stephens Investment Management Group LLC | 1,168,469 | $45,535,237 | 0.82% |